LONDON–(BUSINESS WIRE)–BenevolentAI (Euronext Amsterdam: BAI), a leading clinical-stage AI drug discovery company, announces that it will participate in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco, US from 9-12 January 2023. Joanna Shields, Chief Executive Officer of BenevolentAI is scheduled to present at 14:15 PST (22:15 GMT) on Monday, 9 January 2023. The webcast link and slides will be made available on BenevolentAI’s Investor Relations portal. BenevolentAI